237
Views
0
CrossRef citations to date
0
Altmetric
Articles

The effect of asymmetry and conjugation of biotin decorated nitrogen doped graphene quantum dots on morpholine porphyrin for photodynamic therapy

, , & ORCID Icon
Pages 2944-2961 | Received 19 Sep 2022, Accepted 29 Oct 2022, Published online: 22 Nov 2022
 

Abstract

Novel asymmetric 5-(4-bromo)-10-15-20-tris-(4-morpholine)porphyrin (complex 1) and its Zn derivative (2) were synthesized, and the latter was quaternized to give 2Q, and their photodynamic therapy (PDT) activities were compared to those of the symmetric tetra-morpholine porphyrin (3) and its respective quaternized analogue (3Q). Respective porphyrins were further conjugated to biotin-nitrogen doped graphene quantum dots (B-NGQDs) through π-π stacking. It was observed that the asymmetric complexes and their conjugates had high singlet oxygen quantum yields when compared to the symmetrical porphyrin and their conjugates. PDT studies were performed using MCF-7 breast cancer line. It was observed that all the complexes/conjugates have negligible dark toxicity, and 2Q-B-NGQDs had a highest PDT efficiency with cell viability of 14.4% and IC50 of 1.41 µg/mL.

Graphical Abstract

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

This work was supported by the Department of Science and Technology (DST)/Nanotechnology (NIC) and National Research Foundation (NRF) of South Africa through DST/NRF South African Research Chairs Initiative for Professor of Medicinal Chemistry and Nanotechnology (UID 62620) and Rhodes University.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.